Shi Yu Zhang
- Oncology top 10%
- Cancer-related Molecular Pathways 7
-
- Cancer Genomics and Diagnostics 2
- Otorhinolaryngology top 10%
-
- Cancer Research and Treatments 1
-
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Cell death mechanisms and regulation 1
- Hedgehog Signaling Pathway Studies 1
-
- Berberine and alkaloids research 1
- Co-authors
- Andres J. Klein–SzantoTamra GoodrowJohn A. RidgeEdward R. SauterDennis A. CarsonShin‐ichiro MitsunagaTsutomu NoboriJames S. Babb
- Journals
- Molecular Carcinogenesis (2 papers)Journal of Bioactive and Compatible Polymers (1 paper)PubMed (6 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Shi Yu Zhang
9 papers receiving 436 citations
Peers
Comparison fields: 5 of 48
- Oncology 293
- Cancer Research 111
- Otorhinolaryngology 25
- Biotechnology 38
- Molecular Biology 273
Countries citing papers authored by Shi Yu Zhang
This map shows the geographic impact of Shi Yu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Yu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Yu Zhang more than expected).
Fields of papers citing papers by Shi Yu Zhang
This network shows the impact of papers produced by Shi Yu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Yu Zhang. The network helps show where Shi Yu Zhang may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Shi Yu Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2017 | 9 | |
| 3 | 2002 | 12 | |
| 4 | 2002 | 34 | |
| 5 | Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas. | 2001 | 6 |
| 6 | E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. | 2000 | 46 |
| 7 | E2F-1: a proliferative marker of breast neoplasia. | 2000 | 86 |
| 8 | Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. | 1997 | 33 |
| 9 | Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. | 1994 | 210 |
About Shi Yu Zhang
Shi Yu Zhang is a scholar working on Oncology, Pharmaceutical Science and Cancer Research, having authored 9 papers that have together received 437 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer Genomics and Diagnostics (2 papers), Berberine and alkaloids research (1 paper), Cell death mechanisms and regulation (1 paper), Cancer Research and Treatments (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Oncology (293 citations), Cancer Research (111 citations) and Otorhinolaryngology (25 citations). Shi Yu Zhang has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Andres J. Klein–Szanto, Tamra Goodrow, John A. Ridge, Edward R. Sauter, Dennis A. Carson, Shin‐ichiro Mitsunaga, Tsutomu Nobori, James S. Babb, Xu Guo and D. Gale Johnson. Their work appears in journals such as Molecular Carcinogenesis, Journal of Bioactive and Compatible Polymers and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.